POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER IN PATIENTS UNDER PRIMARY TACROLIMUS (FK-506) IMMUNOSUPPRESSION

Citation
Dg. Deschler et al., POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER IN PATIENTS UNDER PRIMARY TACROLIMUS (FK-506) IMMUNOSUPPRESSION, Archives of otolaryngology, head & neck surgery, 121(9), 1995, pp. 1037-1041
Citations number
32
Categorie Soggetti
Otorhinolaryngology,Surgery
ISSN journal
08864470
Volume
121
Issue
9
Year of publication
1995
Pages
1037 - 1041
Database
ISI
SICI code
0886-4470(1995)121:9<1037:PLDIPU>2.0.ZU;2-5
Abstract
Posttransplantation lymphoproliferative disorder (PTLD) is a well-desc ribed complication of the systemic immunosuppression required for succ essful organ transplantation, Lesions of PTLD often occur in the regio n of the head and neck and require otolaryngologic evaluations. Althou gh the majority of reported cases of PTLD are associated with cyclospo rine immunosuppression, recently, PTLD has been described in patients treated solely with the newer systemic immunosuppressive agent tacroli mus (FK 506). As an introduction to tacrolimus and to PTLD as one of i ts complications, a case of PTLD presenting as airway obstruction in a child treated solely with tacrolimus immunosuppression is described. In addition, a review of tacrolimus and PTLD in patients under tacroli mus immunosuppression is presented to familiarize the otolaryngologist with this important new immunosuppressive agent and a potential compl ication of its use.